Piper Jaffray Upgrades Genomic Health Inc. (GHDX) to Overweight
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray upgraded Genomic Health Inc. (NASDAQ: GHDX) from Neutral to Overweight, maintains price target of $27.00.
For more ratings news on Genomic Health Inc. click here and for the rating history of Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $20.82 yesterday.
For more ratings news on Genomic Health Inc. click here and for the rating history of Genomic Health Inc. click here.
Shares of Genomic Health Inc. closed at $20.82 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- Jefferies Upgrades Minerva Neurosciences (NERV) to Buy
- Keefe, Bruyette & Woods Upgrades Nayax (NYAX) to Outperform
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
